Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Canaries, coal mines and the drug supply

Nature Biotechnology volume 26, pages 624–626 (2008)Cite this article

The heparin safety crisis sends a strong signal that urgent changes in regulatory and manufacturing oversight are needed to ensure the safety of the global drug supply.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Foreign drug manufacturing and FDA inspections.

References

  1. Guerrini M . et al. Nat. Biotechnol. advance online publication, doi:10.1038/nbt1407 (23 April 2008).

  2. Kishimoto, T.K. et al. N. Engl. J. Med. published online, doi: 10.1056/NEJMoa0803200 (23 April 2008).

  3. Crosse, M. Drug Safety: Preliminary Findings Suggest Weaknesses in FDA's Program for Inspecting Foreign Drug Manufacturers. Statement of Marcia Crosse, director of Healthcare, Government Accountability Office, before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, November 1, 2007 (US Government Accountability Office, Washington, DC, 2007). Accessed April 29, 2008. <http://www.gao.gov/new.items/d08224t.pdf>

    Google Scholar 

  4. Casadevall, N. et al. N. Engl. J. Med. 346, 469–475 (2002).

    Article  CAS  Google Scholar 

  5. FDA Science Board Subcommittee on Science and Technology. FDA Science and Mission at Risk: Report of the Subcommittee on Science and Technology. (US Food and Drug Administration, Rockville, MD, USA, November 2007).

  6. Summary of FDAs FY 2009 budget. Accessed April 30, 2008. <http://www.fda.gov/oc/factsheets/budget2009.html>

Download references

Author information

Authors and Affiliations

  1. Jeffrey M. Leiden is at Clarus Ventures, 101 Main St., Suite 1210, Cambridge, Massachusetts 02142, USA. jleiden@clarusventures.com,

    Jeffrey M Leiden

Authors
  1. Jeffrey M Leiden
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leiden, J. Canaries, coal mines and the drug supply. Nat Biotechnol 26, 624–626 (2008). https://doi.org/10.1038/nbt0608-624

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0608-624

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing